[Histopathological classification of 3,510 cases with eyelid tumor].

Zhonghua Yan Ke Za Zhi

Department of Ophthalmology, Eye and Ear Nose Throat Hospital, Shanghai Medical University.

Published: November 1996

AI Article Synopsis

  • The study analyzed 3,510 cases of eyelid tumors from 1953-1992 to categorize their histopathological types.
  • The leading malignant eyelid tumors were basal cell carcinoma, meibomian gland carcinoma, and squamous cell carcinoma, while benign tumors included papillomas and pigmented nevi.
  • The research concluded that proper classification of eyelid tumors aids in accurate histopathological diagnosis.

Article Abstract

Objective: To study the histopathological classification of eyelid tumor.

Method: The pathological specimens of 3,510 cases with eyelid tumor examined between 1953-1992 were retrospectively analyzed. RESULTS The 5 leading malignant lid tumors were basal cell carcinomas (430 cases, 37.6%), meibomian gland carcinomas (363, 31.7%), squamous cell carcinomas (216 cases, 18.9%), melanomas (56 cases, 4.9%) and malignant lymphomas (21 cases, 1.8%). The 5 leading benign lid tumors including papillomas (658 cases, 27.9%), pigmented nevi (578 cases, 24.4%), cysts (427 cases, 18.1%), angiomas (222 cases, 9.4% including 10 lymphangiomas) and verrucae (212 cases, 9.0%). Rare tumors of the eyelid included one case of each of the following tumors: reticulum cell sarcoma, adenocystic carcinoma, malignant mesenchymoma, mucinous adenocarcinoma, Bowen's disease, basosquamous carcinoma, basosebacious carcinoma, teratoma, granular cell tumor (myoblastoma), angiolymphoid hyperplasia with eosinophilia, osteoma, etc.

Conclusion: The classification and differentiation in type of eyelid tumor are beneficial to the histopathological diagnosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cases
11
3510 cases
8
cases eyelid
8
eyelid tumor
8
lid tumors
8
cell carcinomas
8
eyelid
5
[histopathological classification
4
classification 3510
4
eyelid tumor]
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!